john_a

John Aston, OBE

Chairman

John Aston was appointed as a non-executive Director of the Company on 23 February 2011 and served as Chairman of the Audit Committee from April 2011 to July 2016. He was chief financial officer of Astex Therapeutics Limited between January 2007 and May 2010, and was chief financial officer of Cambridge Antibody Technology for ten years to 2006. Prior to this he was a director in investment banking with Schroders in London and previously worked for British Technology Group and Price Waterhouse. He is a Chartered Accountant and has a degree in Mathematics from Cambridge University. He is currently also a director of Polar Capital Global Healthcare Trust Plc.

Disclaimer

  • You are seeing this because you are accessing IBT’s website for the first time.
  • The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.
  • An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.
  • The material on this website is intended to be viewed only by persons resident in the EEA.
  • The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.
  • No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.
  • The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).